Halozyme Therapeutics, Inc. · NASDAQ:HALO
Daly James M received 1,169 Halozyme Therapeutics, Inc. shares as an award (Form 4)
Traded Oct 1, 2026 · Filed Oct 2, 2026
On Oct 1, 2026, Daly James M (Director) received 1,169 Halozyme Therapeutics, Inc. shares as an award, leaving 1,169 shares. Filed Oct 2, 2026 (Form 4).
- Awarded
- 1,169 shares
- Holding after
- 1,169 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Restricted Stock Units | Award | 1,169 | 1,169 | Direct |